XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 19,184 $ 15,216 $ 36,568 $ 29,273
Selling, general and administrative 20,541 19,532 42,092 40,267
Restructuring 2,128   2,128  
Total operating expenses 41,853 34,748 80,788 69,540
Loss from operations (11,640) (6,835) (25,786) (16,683)
Non-operating expense, net:        
Foreign exchange gain (loss) 49 (104) (144) (302)
Interest expense (2,181) (1,348) (3,793) (2,728)
Other income (expense), net 539 (30) 926 (812)
Total non-operating expense, net (1,593) (1,482) (3,011) (3,842)
Loss before income taxes (13,233) (8,317) (28,797) (20,525)
Provision for income taxes 98 78 175 154
Net loss (13,331) (8,395) (28,972) (20,679)
Net loss attributable to noncontrolling interest (56) (6) (78) (6)
Net loss attributable to Cerus Corporation $ (13,275) $ (8,389) $ (28,894) $ (20,673)
Net loss per share attributable to Cerus Corporation        
Basic $ (0.07) $ (0.05) $ (0.16) $ (0.12)
Diluted $ (0.07) $ (0.05) $ (0.16) $ (0.12)
Weighted average shares outstanding:        
Basic 180,611 176,944 179,449 175,718
Diluted 180,611 176,944 179,449 175,718
Product        
Revenue $ 38,853 $ 40,999 $ 69,827 $ 78,443
Cost of revenue 17,515 19,718 31,202 37,794
Gross profit 21,338 21,281 38,625 40,649
Government Contract        
Revenue $ 8,875 $ 6,632 $ 16,377 $ 12,208